Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-11-20
2007-11-20
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253100, C514S299000, C514S304000, C514S316000, C514S318000, C514S336000, C514S343000, 34, 34, C546S112000, C546S125000, C546S187000, C546S193000, C546S279100, C546S284700
Reexamination Certificate
active
10488579
ABSTRACT:
Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy.
REFERENCES:
patent: WO 00/25791 (2000-05-01), None
patent: WO 01/66540 (2001-09-01), None
Wermuth, C.G. (ed.), “Chapter 13: Molecular Variations Based on Isosteric Replacements”,The Practice of Medicinal Chemistry, pp. 204-237, Academic Press Ltd., Copyright (1996), XP-002190259.
Bamford Mark James
Dean David Kenneth
Naylor Antoinette
Takle Andrew Kenneth
Wilson David Matthew
Dentz Bernard
Hsu Grace C.
Kinzig Charles M.
McCarthy Mary E.
SmithKline Beecham P.L.C.
LandOfFree
Nitrogen-containing heterocyclic compounds and their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitrogen-containing heterocyclic compounds and their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrogen-containing heterocyclic compounds and their use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3835934